Related Experiment Video

Updated: May 28, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

[The values of serum cytokines in chronic lung disease in newborn]

Lidija Banjac1

  • 1Institut za bolesti dece, Centar za neonatologiju, Klinicki centar Crne Gore Podgorica. drbanjac@t-com.me

Medicinski Pregled
|October 6, 2011
PubMed

Insights

This study investigated insulin-like growth factor I (IGF-I) in newborns at risk for chronic lung disease. Low IGF-I levels in preterm infants were not found to be significantly correlated with developing this condition.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Endocrinology

Context:

  • Chronic lung disease (CLD) is a significant complication in newborns requiring mechanical ventilation.
  • Early identification of infants at risk for CLD is crucial for timely intervention.
  • Insulin-like growth factor I (IGF-I) has been implicated in lung development and repair.

Purpose:

  • To investigate the hypothesis that low serum insulin-like growth factor I (IGF-I) levels at 33 post-conceptual weeks are associated with the development of chronic lung disease in preterm newborns.
  • To evaluate the potential of IGF-I as a biomarker for triaging newborns at risk for CLD.

Summary:

  • A prospective cohort study included preterm newborns (≤33 gestational weeks) and measured serum IGF-I levels at 33 post-conceptual weeks using enzyme immunoassay.
  • Results confirmed a statistically significant correlation between gestational age and birth weight with serum IGF-I levels.
  • No statistically significant correlation was found between serum IGF-I values and the development of chronic lung disease in newborns.

Impact:

  • The study suggests that IGF-I may not be a reliable biomarker for predicting chronic lung disease in newborns at the assessed time point.
  • Further research is warranted to explore the role of IGF-I at different stages of prematurity-related diseases.
  • Potential for refining the timing of IGF-I measurements to identify a significant correlation with chronic lung disease.
Abstract

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...